Hemolytic uremic syndrome: pathogenesis and update of interventions

All blood, No stool: enterohemorrhagic Escherichia coli O157:H7 infection

(2010) Jang W. Yoon et al.   Journal of Veterinary Science

Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections

(2009) Antonio Serna et al.   CURRENT OPINION IN GASTROENTEROLOGY

Novel Subtilase Cytotoxin Produced by Shiga-Toxigenic Escherichia coli Induces Apoptosis in Vero Cells via Mitochondrial Membrane Damage

(2009) G. Matsuura et al.   INFECTION AND IMMUNITY

Shiga toxin-producing Escherichia coli O157 in beef and chicken burgers, and chicken carcasses in Buenos Aires, Argentina

(2009) Isabel Chinen et al.   INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY

Shiga Toxin Activates Complement and Binds Factor H: Evidence for an Active Role of Complement in Hemolytic Uremic Syndrome

(2009) Dorothea Orth et al.   JOURNAL OF IMMUNOLOGY

Host and pathogen determinants of verocytotoxin-producing Escherichia coli -associated hemolytic uremic syndrome

(2009) Mohamed A Karmali   KIDNEY INTERNATIONAL

Relationship between Escherichia coli O157:H7 and diabetes mellitus

(2009) Rita S Suri et al.   KIDNEY INTERNATIONAL

Verotoxin biology: molecular events in vascular endothelial injury

(2009) Tania N Petruzziello et al.   KIDNEY INTERNATIONAL

Interventions for Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura: A Systematic Review of Randomized Controlled Trials

(2008) Mini Michael et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Macropinocytosis in Shiga toxin 1 uptake by human intestinal epithelial cells and transcellular transcytosis

(2008) Irina Malyukova et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Molecular Analysis as an Aid To Assess the Public Health Risk of Non-O157 Shiga Toxin-Producing Escherichia coli Strains

(2008) B. K. Coombes et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Glycosphingolipids are not pivotal receptors for Subtilase cytotoxin in vivo: Sensitivity analysis with glycosylation-defective mutant mice

(2008) Yuji Kondo et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Subtilase cytotoxin, produced by Shiga-toxigenic Escherichia coli, transiently inhibits protein synthesis of Vero cells via degradation of BiP and induces cell cycle arrest at G1 by downregulation of cyclin D1

(2008) Naoko Morinaga et al.   CELLULAR MICROBIOLOGY

Management of diarrhea-associated hemolytic uremic syndrome in children

(2008) Kazumoto Iijima et al.   Clinical and Experimental Nephrology

Intracellular Neutralization of Shiga Toxin 2 by an A Subunit-Specific Human Monoclonal Antibody

(2008) G. Krautz-Peterson et al.   INFECTION AND IMMUNITY

Mouse Model of Hemolytic-Uremic Syndrome Caused by Endotoxin-Free Shiga Toxin 2 (Stx2) and Protection from Lethal Outcome by Anti-Stx2 Antibody

(2008) K. A. D. Sauter et al.   INFECTION AND IMMUNITY

Differential intracellular transport and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide‐containing lipid assemblies

(2008) Patty Tam et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Early erythropoietin reduced the need for red blood cell transfusion in childhood hemolytic uremic syndrome—a randomized prospective pilot trial

(2008) Lars Pape et al.   PEDIATRIC NEPHROLOGY

Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)

(2008) Johanna Scheiring et al.   PEDIATRIC NEPHROLOGY